1h Free Analyst Time
The NGS-based RNA-seq market is poised to grow by $3,753.73 mn during 2023-2027, accelerating at a CAGR of 15.34% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased adoption of next-generation sequencing methods, technological advancement in sequencing platforms, and the availability of wide range of next generation sequencing products.
The NGS-based RNA-seq market is segmented as below:
By End-user
- Academic and research centers
- Clinical research
- Pharma companies
- Hospitals
By Technology
- Sequencing by synthesis
- Ion semiconductor sequencing
- Single-molecule real-time sequencing
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the NGS-based RNA-seq market covers the following areas:
- NGS-based RNA-seq market sizing
- NGS-based RNA-seq market forecast
- NGS-based RNA-seq market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global ngs-based rna-seq market: Agilent Technologies Inc., BGI Genomics Co. Ltd., Brooks Automation Inc., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Precigen Inc., Pacific Biosciences of California Inc., PerkinElmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is advances in next-generation sequencing techniques.`
According to the report, one of the major drivers for this market is the increased adoption of next generation sequencing methods.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- BGI Genomics Co. Ltd.
- Brooks Automation Inc.
- DNASTAR Inc.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Hamilton Bonaduz AG
- Illumina Inc.
- Precigen Inc.
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- PierianDx Inc.
- Psomagen Inc.
- QIAGEN NV
- Takara Bio Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- Zymo Research Corp.
